Epithelioid sarcoma in children

被引:18
作者
Gross, E
Rao, BN
Pappo, A
Bowman, L
Shearer, P
Kaste, S
Greenwald, C
Michalkiewicz, E
Pratt, C
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT SURG, MEMPHIS, TN 38105 USA
[2] ST JUDE CHILDRENS RES HOSP, DEPT HEMATOL ONCOL, MEMPHIS, TN 38105 USA
[3] ST JUDE CHILDRENS RES HOSP, DEPT DIAGNOST IMAGING, MEMPHIS, TN 38105 USA
[4] ST JUDE CHILDRENS RES HOSP, DEPT RADIAT ONCOL, MEMPHIS, TN 38105 USA
[5] UNIV TENNESSEE, MEMPHIS, TN USA
关键词
epithelioid sarcoma;
D O I
10.1016/S0022-3468(96)90043-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Literature regarding the natural history and prognosis of epithelioid sarcoma in the pediatric population is sparse. During the past 11 years, eight patients with epithelioid sarcoma were treated at St Jude Children's Research Hospital. Of the eight children, six of whom were male, seven presented with localized disease and one with metastatic disease. The primary tumor was located in the upper extremity in four patients; the other sites were the scalp, external ear, back, and mediastinum. The mean duration of symptoms before diagnosis was 8.3 months (range, 1 to 12 months). Surgical treatment comprising amputation or wide local excision was performed in six patients, three of whom had additional lymph node dissection. Three patients received multiagent chemotherapy, and four patients were treated with supplementary radiation. Two patients died of progressive local and distant disease within 9 months of diagnosis. The other six patients are alive and have no evidence of disease 12 months to 10 years 6 months after the completion of treatment. Copyright (C) 1996 by W.B. Saunders Company.
引用
收藏
页码:1663 / 1665
页数:3
相关论文
共 16 条
[1]   EPITHELIOID SARCOMA - DIAGNOSIS, PROGNOSTIC INDICATORS, AND TREATMENT [J].
CHASE, DR ;
ENZINGER, FM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1985, 9 (04) :241-263
[2]  
DEVRIES J, 1989, J PEDIATR SURG, V24, P186
[3]  
ENZINGER FM, 1970, CANCER-AM CANCER SOC, V26, P1029, DOI 10.1002/1097-0142(197011)26:5<1029::AID-CNCR2820260510>3.0.CO
[4]  
2-R
[5]  
ENZINGER FM, 1988, SOFT TISSUE TUMORS, P929
[6]  
Harmer MH., 1982, TNM CLASSIFICATION P, P23
[7]  
MAURER HM, 1988, CANCER-AM CANCER SOC, V61, P209, DOI 10.1002/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO
[8]  
2-L
[9]  
MAZERON JJ, 1987, CANCER, V60, P1800, DOI 10.1002/1097-0142(19871015)60:8<1800::AID-CNCR2820600822>3.0.CO
[10]  
2-N